Publications by authors named "Ming S Tsao"

39Publications

Evosep One Enables Robust Deep Proteome Coverage Using Tandem Mass Tags while Significantly Reducing Instrument Time.

J Proteome Res 2019 05 12;18(5):2346-2353. Epub 2019 Apr 12.

Department of Molecular Genetics , University of Toronto , 1 King's College Circle , Toronto , ON , Canada M5S 1A8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.9b00082DOI Listing
May 2019

Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist.

Arch Pathol Lab Med 2018 May 26;142(5):645-661. Epub 2018 Feb 26.

From the Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom (Dr Nicholson); the Department of Pathology, The Princess Margaret Cancer Centre, Toronto, Ontario, Canada (Dr Tsao); the Department of Pathology (Dr Travis) and the Thoracic Service, Department of Surgery (Dr Rusch), Memorial Sloan-Kettering Cancer Center, New York, New York; the Departments of Pathology (Dr Patil) and Thoracic and Cardiovascular Surgery (Dr Rice), Cleveland Clinic, Cleveland, Ohio; the Departement de Biopathologie, Cancer Center Leon Bernard, Lyon, France (Dr Galateau-Salle); the Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy (Dr Marino); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington (Dr Butnor); the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe); the Department of Thoracic Surgery, New York University, New York, New York (Dr Pass); the Department of Thoracic Surgery, Yale University, New Haven, Connecticut (Dr Detterbeck); the Department of Thoracic Surgery, Keio University, Tokyo, Japan (Dr Asamura); and the Thoracic Surgery Service, Hospital Universitari Mutua Terrassa, University of Barcelona, and CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain (Dr Rami-Porta).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0245-RADOI Listing
May 2018

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Arch Pathol Lab Med 2018 Mar 22;142(3):321-346. Epub 2018 Jan 22.

From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0388-CPDOI Listing
March 2018

Uncommon EGFR mutations in advanced non-small cell lung cancer.

Lung Cancer 2017 07 27;109:137-144. Epub 2017 Apr 27.

Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.04.016DOI Listing
July 2017

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2017 Mar 7;141(3):437-444. Epub 2016 Nov 7.

From the Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota (Drs Roden, Aubry, and Yi); the Department of Pathology, University of Colorado, Denver (Dr Aisner); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology and Genomic Medicine, Methodist Hospital, Houston, Texas (Drs Barrios, Cagle, Ge, and Miller); the Department of Pathology, Mount Sinai Health System, Icahn School of Medicine, New York, New York (Dr Beasley); the Department of Pathology, University of São Paolo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); Département de Biopathologie, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, La Tronche, France (Dr Lantuejoul); the Department of Pathology, New York University Langone Medical Center, New York, New York (Dr Moreira); the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Dr Smith); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0459-SADOI Listing
March 2017

Comprehensive proteome analysis of fresh frozen and optimal cutting temperature (OCT) embedded primary non-small cell lung carcinoma by LC-MS/MS.

Methods 2015 Jun 23;81:50-5. Epub 2015 Feb 23.

Program in Molecular Structure and Function, The Hospital For Sick Children, 686 Bay Street, Toronto, Ontario M5G 0A4, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2015.02.008DOI Listing
June 2015

Individual investigator profiles of biospecimen use in cancer research.

Biopreserv Biobank 2014 Jun 11;12(3):192-8. Epub 2014 Jun 11.

1 Tumour Tissue Repository, Trev and Joyce Deeley Research Centre, BC Cancer Agency , Victoria, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/bio.2013.0092
Publisher Site
http://dx.doi.org/10.1089/bio.2013.0092DOI Listing
June 2014

An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators.

J Thorac Oncol 2014 May;9(5):631-8

*Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado; †Department of Pathology Brigham and Women's Hospital, Boston, Massachusetts; ‡Institute of Pathology, Charité University Hospital Berlin, Germany; §Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, The Netherlands; ‖Princess Margaret Hospital, University Health Network, University of Toronto, Ontario, Canada; ¶Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Kanokoden, Chikusa-ku, Nagoya, Japan; #Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio; ** Department of Pathology, University of Colorado, Aurora, Colorado; and ††University of Colorado Comprehensive Cancer Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153027
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186652PMC
May 2014

Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.

Histopathology 2014 May 29;64(6):826-39. Epub 2014 Jan 29.

Department of Pathology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.12331
Publisher Site
http://dx.doi.org/10.1111/his.12331DOI Listing
May 2014

Odin (ANKS1A) modulates EGF receptor recycling and stability.

PLoS One 2013 25;8(6):e64817. Epub 2013 Jun 25.

Program in Molecular Structure and Function, Hospital for Sick Children, Toronto, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0064817PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692516PMC
January 2014

Pathologic assessment of radiofrequency ablation of pulmonary metastases.

J Vasc Interv Radiol 2010 Nov 29;21(11):1689-96. Epub 2010 Sep 29.

Mount Sinai Hospital, Department of Medical Imaging, Room 564, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2010.06.023DOI Listing
November 2010

Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in non-small cell lung cancer?

J Nucl Med 2010 Oct 16;51(10):1517-23. Epub 2010 Sep 16.

Department of Radiotherapy, Shanghai Cancer Center, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.110.077974DOI Listing
October 2010

PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings?

Int J Radiat Oncol Biol Phys 2010 Jul 14;77(3):699-706. Epub 2009 Oct 14.

Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.05.028DOI Listing
July 2010

Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.

J Clin Oncol 2008 Sep 30;26(26):4319-25. Epub 2008 Jun 30.

Princess Margaret Hospital, University Health Network, Bras Family Drug Development Program, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.8808DOI Listing
September 2008

Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

J Thorac Cardiovasc Surg 2007 Jan;133(1):111-6

Division of Thoracic Surgery, Toronto General Hospital, University of Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2006.06.044DOI Listing
January 2007

High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals.

Nano Lett 2006 Dec;6(12):2881-6

Division of Applied Molecular Oncology, Ontario Cancer Institute, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/abs/10.1021/nl062111n
Publisher Site
http://dx.doi.org/10.1021/nl062111nDOI Listing
December 2006

The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.

Cancer Res 2006 May;66(10):5330-7

Division of Cancer Genomics and Proteomics, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0037DOI Listing
May 2006

Early combined treatment with carboplatin and the MMP inhibitor, prinomastat, prolongs survival and reduces systemic metastasis in an aggressive orthotopic lung cancer model.

Lung Cancer 2003 Dec;42(3):335-44

Department of Surgery, Division of Thoracic Surgery, Toronto General Hospital, University of Toronto, Suite 10 EN-230, 200 Elizabeth Street, Toronto, Ont., Canada M5G2C4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(03)00355-6DOI Listing
December 2003

Bronchogenic carcinoma after solid organ transplantation.

Ann Thorac Surg 2003 Feb;75(2):367-71

Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-4975(02)04379-5DOI Listing
February 2003